Thailand’s Evolving Cannabis Policy
In an unexpected turn of events, the government of Thailand announced a significant shift in its cannabis policy on June 25, 2025. This change, reported by the BBC, effectively restricts cannabis access to medical use only after a brief period of wider availability. As part of the new regulations, unpermitted consumption of cannabis is set to become a criminal offense once again, a move signaled by the public health minister.
New Regulations on Cannabis Use
The latest changes were formalized in the Royal Gazette, marking a notable pivot for a country that had only recently become synonymous with cannabis reform. Specifically, the government has redefined cannabis as a controlled herb that necessitates a prescription for purchase. Only licensed practitioners, including traditional healers, can issue prescriptions, which must detail essential information, such as the dosage for treatment. Medical cannabis prescriptions are capped at a maximum usage duration of 30 days, adding a layer of regulation aimed at ensuring responsible consumption.
The Rise of Smuggling
This legislative shift has coincided with increasing concerns about cannabis smuggling, particularly from Thailand to other nations. The issue has intensified, especially following the recent withdrawal of the political party that previously championed cannabis legalization. These developments suggest that the motivations behind the tightening of regulations might be multifaceted, including political pressures and public safety concerns.
Key Aspects of the New Regulations
The newly established guidelines stipulate various parameters regarding cannabis use and sales. Here are some focal points:
- Controlled Herbs: Only cannabis flowers are classified as controlled substances.
- Special Licenses: These are necessary for research, sales, exporting, or processing of cannabis flowers. Licensees are required to submit regular reports detailing their sources and uses.
- Advertising Restrictions: Cannabis advertising is strictly prohibited, along with sales near sensitive locations such as temples and parks.
As of June 26, the Department of Thai Traditional and Alternative Medicine (DTAM) has identified over 15 medical conditions that qualify for cannabis prescriptions, including cancer, asthma, chronic pain, and depression.
Historical Context
Thailand’s journey with cannabis legislation has been a rollercoaster of rapid progress and sudden reversals. In 2022, it became the first Asian country to legalize recreational cannabis, following its earlier legalization of medical use in 2018. However, Prime Minister Srettha Thavisin’s administration soon expressed an intention to retract the more lenient regulations. The intent was to return cannabis to being classified as a medical-only substance, reinforcing its status as a controlled plant.
In a surprising twist in July 2024, Deputy Prime Minister Anutin Charnvirakul indicated that cannabis would not be reclassified as a narcotic, contradicting earlier proposals. This unexpected decision had helped boost Thailand’s burgeoning cannabis industry, which was on track to reach $1.2 billion in revenue by 2025.
Future Implications
With the recent regulatory changes, a cloud of uncertainty looms over those engaged in the cannabis industry in Thailand. As the landscape rapidly transforms, stakeholders are left navigating a maze of regulations that could have vast implications for medical patients, traditional practitioners, and the broader cannabis market.
As these developments unfold, it will be crucial to observe how the Thai government manages the intersection of public health, safety, and economic interests in its approach to cannabis moving forward.